Avior Wealth Management LLC Has $286,000 Stock Holdings in MetLife, Inc. (NYSE:MET)

Avior Wealth Management LLC lessened its holdings in MetLife, Inc. (NYSE:MET) by 10.7% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 4,327 shares of the financial services provider’s stock after selling 517 shares during the quarter. Avior Wealth Management LLC’s holdings in MetLife were worth $286,000 as of its most recent SEC filing.

A number of other large investors have also recently modified their holdings of the business. Zurcher Kantonalbank Zurich Cantonalbank boosted its holdings in shares of MetLife by 15.7% in the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 272,742 shares of the financial services provider’s stock valued at $18,036,000 after purchasing an additional 37,065 shares in the last quarter. United Asset Strategies Inc. boosted its holdings in shares of MetLife by 10.3% in the 4th quarter. United Asset Strategies Inc. now owns 12,266 shares of the financial services provider’s stock valued at $811,000 after purchasing an additional 1,142 shares in the last quarter. Flputnam Investment Management Co. acquired a new stake in shares of MetLife in the 4th quarter valued at $284,000. Cornercap Investment Counsel Inc. boosted its holdings in shares of MetLife by 1.5% in the 4th quarter. Cornercap Investment Counsel Inc. now owns 31,978 shares of the financial services provider’s stock valued at $2,115,000 after purchasing an additional 486 shares in the last quarter. Finally, Waldron Private Wealth LLC boosted its holdings in shares of MetLife by 10.8% during the 4th quarter. Waldron Private Wealth LLC now owns 4,875 shares of the financial services provider’s stock valued at $322,000 after acquiring an additional 476 shares in the last quarter. Institutional investors and hedge funds own 89.81% of the company’s stock.

Insider Transactions at MetLife

In other news, insider Ramy Tadros sold 4,026 shares of MetLife stock in a transaction dated Wednesday, March 13th. The stock was sold at an average price of $71.90, for a total value of $289,469.40. Following the completion of the transaction, the insider now directly owns 146,981 shares of the company’s stock, valued at approximately $10,567,933.90. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. In related news, EVP Bill Pappas sold 27,000 shares of the business’s stock in a transaction dated Monday, March 18th. The stock was sold at an average price of $72.27, for a total value of $1,951,290.00. Following the completion of the sale, the executive vice president now directly owns 57,768 shares of the company’s stock, valued at approximately $4,174,893.36. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, insider Ramy Tadros sold 4,026 shares of the business’s stock in a transaction dated Wednesday, March 13th. The shares were sold at an average price of $71.90, for a total value of $289,469.40. Following the completion of the sale, the insider now directly owns 146,981 shares of the company’s stock, valued at $10,567,933.90. The disclosure for this sale can be found here. Corporate insiders own 0.32% of the company’s stock.

Analyst Upgrades and Downgrades

MET has been the topic of several recent research reports. Wells Fargo & Company raised their price objective on MetLife from $83.00 to $86.00 and gave the company an “overweight” rating in a report on Thursday, April 11th. Piper Sandler raised their price objective on MetLife from $74.00 to $85.00 and gave the company an “overweight” rating in a report on Friday, April 5th. Keefe, Bruyette & Woods raised their price objective on MetLife from $82.00 to $87.00 and gave the company an “outperform” rating in a report on Wednesday, April 10th. The Goldman Sachs Group raised MetLife from a “neutral” rating to a “buy” rating and raised their price objective for the company from $70.00 to $80.00 in a report on Monday, January 8th. Finally, UBS Group cut their price objective on MetLife from $87.00 to $82.00 and set a “buy” rating on the stock in a report on Monday, February 5th. Two equities research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $79.23.

MetLife Stock Up 1.7 %

Shares of MET opened at $71.11 on Friday. The company has a market capitalization of $51.41 billion, a PE ratio of 38.86, a PEG ratio of 0.53 and a beta of 1.04. MetLife, Inc. has a 12 month low of $48.95 and a 12 month high of $74.68. The stock’s 50-day moving average price is $71.12 and its two-hundred day moving average price is $66.77. The company has a current ratio of 0.16, a quick ratio of 0.16 and a debt-to-equity ratio of 0.53.

MetLife (NYSE:MET) last posted its quarterly earnings data on Wednesday, January 31st. The financial services provider reported $1.93 earnings per share for the quarter, missing the consensus estimate of $1.95 by ($0.02). MetLife had a return on equity of 19.48% and a net margin of 2.36%. The business had revenue of $18.72 billion during the quarter, compared to the consensus estimate of $18.07 billion. On average, analysts anticipate that MetLife, Inc. will post 8.71 EPS for the current year.

MetLife Company Profile

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.